Lithium Carbonate Extended-Release Tablets
Item Name Code (INC) 45498
![]() |
Additional Information for Lithium Carbonate Extended-Release Tablets
Lithium Carbonate Extended-Release Tablets are a type of medication that belongs to the supply class Drugs And Biologicals in the supply group Medical, Dental, And Veterinary Equipment And Supplies.
Lithium Carbonate is a mood stabilizer that is primarily used to treat bipolar disorder. It helps to control and prevent episodes of mania (abnormally elevated mood) and depression in individuals with bipolar disorder.
The extended-release formulation of Lithium Carbonate allows for a slow and steady release of the medication into the body, providing a more consistent and prolonged effect. This helps to maintain stable lithium levels in the blood, which is important for its therapeutic benefits.
These tablets are typically prescribed by healthcare professionals and should be taken as directed. It is important to follow the prescribed dosage and frequency, as well as any specific instructions provided by the healthcare provider.
As with any medication, there may be potential side effects and precautions associated with the use of Lithium Carbonate Extended-Release Tablets. It is important to discuss any concerns or questions with a healthcare professional before starting or making any changes to the medication regimen.
Please note that this information is for informational purposes only and should not replace the advice of a healthcare professional.
Related Item Names for INC 45498 Lithium Carbonate Extended-Release Tablets
NATO Stock Numbers with Item Name 45498 Lithium Carbonate Extended-Release Tablets Page 1 of 1
- 3400933727369
- RNCC: 3 | RNVC: 2 | DAC: 4
- LITHOBID TABLETS
- RNCC: 5 | RNVC: 1 | DAC: 4
- LITHOBID
- RNCC: 5 | RNVC: 1 | DAC: 6
- NDC00083-0065-40
- RNCC: 3 | RNVC: 2 | DAC: 6